Our goal is to determine the role of actin-myosin structural dynamics in the molecular mechanism of muscle contraction. Structures, dynamics, and interactions of myosin and actin are fundamental in understanding mechanisms of contraction and its regulation. We focus on dynamic interactions of actin with the catalytic domain of myosin, and extend this investigation to include myosin's light-chain domain and myosin binding protein-C (CPro). To gain insight into structure-functional correlation, we vary active-site ligands, protein isoforms, phosphorylation, mutation, crosslinking, and drugs. Our approach is distinguished by our emphasis on dynamics as well as structure, and on the elusive weak-binding states of actomyosin as well as the more stable strong-binding states. Our core technology is a unique combination of site-directed protein labeling, coupled with high-resolution and time-resolved spectroscopies, to test and revise detailed mechanistic models for the functional interactions of myosin and actin as they transition from weak- to strong- binding states in force generation.
In Aim 1, fundamental structural dynamics of the myosin catalytic domain (CD) is investigated, using probes designed to test and revise mechanistic models of actin-activated force generation with high resolution in real time. We seek to understand temporal and spatial coordination of this complex motor.
In Aim 2, allosteric changes propagated from the light chain domain (LCD) through the CD to actin will be mapped by probes, with emphasis on regulation by protein isoform and phosphorylation. Similarly, Aim 3 uses the insights of the first two aims to assess structural dynamics of the actomyosin weak and strong interactions perturbed by the presence, isoform, and phosphorylation of CPro. Feasibility (preparations, preliminary data) has been established independently for all three aims, so they are not restrictively interdependent. Instead, the three aims are synergistic, in that they share reagents and are strategically aligned to strengthen each other with new discoveries. Our 3 aims arise from ten novel hypotheses, based on findings from the previous period, converging toward a new synthesis. The assembled research team brings together a powerful combination of techniques and concepts from molecular genetics and cell culture to biophysical spectroscopy and computational simulation, to solve the molecular mechanisms of muscle contraction and regulation. This project remains grounded in fundamental biophysical mechanisms, but it is increasingly clear that the tools developed in this project can pave the way for design of molecular therapies in muscle disease. Once we understand the functions of actomyosin and its regulation, we can look to control these functions. It is anticipated that by th end of the next funding period, this project will generate the most detailed and cohesive structure-function model of muscle contraction and regulation to date, and projects will spin off involving the rational design of gene and drug therapies. More generally, the lessons learned in this project are applicable to a wide range of problems in the biophysics of muscle and molecular motors.

Public Health Relevance

This project aims to determine the molecular requirements for healthy muscle function, in order to pave the way for rational development of therapies for treating muscle diseases, including heart disease and muscular dystrophy.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
2R01AR032961-31
Application #
8651081
Study Section
Special Emphasis Panel (ZRG1-BCMB-N (02))
Program Officer
Boyce, Amanda T
Project Start
1983-12-01
Project End
2019-02-28
Budget Start
2014-03-01
Budget End
2015-02-28
Support Year
31
Fiscal Year
2014
Total Cost
$502,152
Indirect Cost
$166,836
Name
University of Minnesota Twin Cities
Department
Biochemistry
Type
Schools of Medicine
DUNS #
555917996
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Moen, Rebecca J; Klein, Jennifer C; Thomas, David D (2014) Electron paramagnetic resonance resolves effects of oxidative stress on muscle proteins. Exerc Sport Sci Rev 42:30-6
Muretta, Joseph M; Petersen, Karl J; Thomas, David D (2013) Direct real-time detection of the actin-activated power stroke within the myosin catalytic domain. Proc Natl Acad Sci U S A 110:7211-6
Moen, Rebecca J; Thomas, David D; Klein, Jennifer C (2013) Conformationally trapping the actin-binding cleft of myosin with a bifunctional spin label. J Biol Chem 288:3016-24
Prochniewicz, Ewa; Guhathakurta, Piyali; Thomas, David D (2013) The structural dynamics of actin during active interaction with myosin depends on the isoform of the essential light chain. Biochemistry 52:1622-30
Lin, Ava Yun; Prochniewicz, Ewa; Henderson, Davin M et al. (2012) Impacts of dystrophin and utrophin domains on actin structural dynamics: implications for therapeutic design. J Mol Biol 420:87-98
Klein, Jennifer C; Moen, Rebecca J; Smith, Evan A et al. (2011) Structural and functional impact of site-directed methionine oxidation in myosin. Biochemistry 50:10318-27
Prochniewicz, Ewa; Pierre, Anaelle; McCullough, Brannon R et al. (2011) Actin filament dynamics in the actomyosin VI complex is regulated allosterically by calcium-calmodulin light chain. J Mol Biol 413:584-92
Nesmelov, Yuri E; Agafonov, Roman V; Negrashov, Igor V et al. (2011) Structural kinetics of myosin by transient time-resolved FRET. Proc Natl Acad Sci U S A 108:1891-6
Lin, Ava Y; Prochniewicz, Ewa; James, Zachary M et al. (2011) Large-scale opening of utrophin's tandem calponin homology (CH) domains upon actin binding by an induced-fit mechanism. Proc Natl Acad Sci U S A 108:12729-33
Moen, Rebecca J; Johnsrud, Daniel O; Thomas, David D et al. (2011) Characterization of a myosin VII MyTH/FERM domain. J Mol Biol 413:17-23

Showing the most recent 10 out of 74 publications